Maximal expansion capacity with current des platforms: A critical factor for stent selection in the treatment of left main bifurcations?

EuroIntervention

Volumn 8, Issue 11, 2013, Pages 1315-1325

  Foin, Nicolas ^a   Sen, Sayan ^a   Allegria, Eduardo ^b   Petraco, Ricardo ^a   Nijjer, Sukh ^a   Francis, Darrel P ^a   Di Mario, Carlo ^b   Davies, Justin E ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bifurcation; DES; Left main; Stent; Workhorses

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; STAINLESS STEEL; UMIROLIMUS; ZOTAROLIMUS;

ARTICLE; BALLOON; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; HUMAN; IMAGE ANALYSIS; LEFT CORONARY ARTERY; MICRO-COMPUTED TOMOGRAPHY; NOMENCLATURE;

EID: 84878324552     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8I11A200     Document Type: Article

References (28)

1. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR, Torracca L, van Es GA, Leadley K, Dawkins KD, Mohr F. Outcomes inpatients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment inthe Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121:2645-53.
2. Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Chung CH, Lee JW, Lim DS, Rha SW, Lee SG, Gwon HC,Kim HS, Chae IH, Jang Y, Jeong MH, Tahk SJ, Seung KB. Randomized trial of stents versus bypass surgery for left main coronary artery disease. New Engl J Med. 2011,364:1718-27.
3. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, MohrFW; SYNTAX Investigators Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-72.
4. Stankovic G, Darremont O, Ferenc M, Hildick-Smith D, Louvard Y, Albiero R, Pan M, Lassen JF, Lefèvre T. European Bifurcation Club. Percutaneous coronary interventionfor bifurcation lesions: 2008 consensus document from the fourth meeting of the European Bifurcation Club. EuroIntervention. 2009;5:39-49.
5. Basalus MW, van Houwelingen KG, Ankone MJ, Feijen J, von Birgelen C. Micro-computed tomographic assessment following extremely oversized partial postdilatationof drug-eluting stents. EuroIntervention. 2010;6:141-8.
6. Guérin P, Pilet P, Finet G, Gouëffic Y, N'Guyen JM, Crochet D, Tijou I, Pacaud P, Loirand G. Drug-eluting stents in bifurcations: bench study of strut deformation andcoating lesions. Circ Cardiovasc Interv. 2010;3:120-6.
7. Foin N, Secco GG, Ghilencea L, Krams R, Di Mario C. Final proximal post-dilatation is necessary after kissing balloon in bifurcation stenting. EuroIntervention. 2011;7:597-604.
8. Ormiston JA, Webster MW, El Jack S, Ruygrok PN, Stewart JT, Scott D, Currie E, Panther MJ, Shaw B, O'Shaughnessy B. Drug-eluting stents for coronary bifurcations:bench testing of provisional side-branch strategies. Catheter Cardiovasc Interv. 2006;67:49-55. (Pubitemid 43062609)
9. Mortier P, Van Loo D, De Beule M, Segers P, Taeymans Y, Verdonck P, Verhegghe B. Comparison of drug-eluting stent cell size using micro-CT: important data forbifurcation stent selection. EuroIntervention. 2008;4:391-6.
10. Ormiston JA, Webster MW, Ruygrok PN, Stewart JT, White HD, Scott DS. Stent deformation following simulated side-branch dilatation: a comparison of five stentdesigns. Catheter Cardiovasc Interv. 1999;47:258-64. (Pubitemid 29309548)
11. Evaluation of XIENCE PRIME™ Everolimus Eluting Stent System (EECSS) or XIENCE V® EECSS Versus Coronary Artery Bypass Surgery for Effectiveness of Left MainRevascularization. EXCEL Clinical Trial. 2010.
12. Guidance for Industry and FDA Staff - Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems. USDepartment of Health and Human Services. 2010.
13. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosisafter drug-eluting stent implantation. Circulation. 2007;115:2426-34. (Pubitemid 46717965)
14. Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, Fitzgerald PJ, Yock PG; POST Registry Investigators. Predictors and outcomes of stent thrombosis:an intravascular ultrasound registry. Eur Heart J. 2002;23:124-32. (Pubitemid 35204230)
15. Romagnoli E, Sangiorgi GM, Cosgrave J, Guillet E, Colombo A. Drug-eluting stenting: the case for post-dilation. JACC Cardiovasc Interv. 2008;1:22-31.
16. Basalus MW, Tandjung K, van Westen T, Sen H, van der Jagt PK, Grijpma DW, van Apeldoorn AA, von Birgelen C. Scanning electron microscopic assessment ofcoating irregularities and their precursors in unexpanded durable polymer-based drug-eluting stents. Catheter Cardiovasc Interv. 2012;79:644-53.
17. Otsuka Y, Chronos NA, Apkarian RP, Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents. J Invasive Cardiol. 2007;19:71-6.
18. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R. Endothelial cell recoverybetween comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008;52:333-42. (Pubitemid 352001347)
19. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: Importance of delayed healing. ArteriosclerThromb Vasc Biol. 2007;27:1500-10. (Pubitemid 46986103)
20. Russo RJ, Silva PD, Yeager M. Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model. Heart. 2007;93:1609-15. (Pubitemid 350205561)
21. Berry JL, Santamarina A, Moore JE Jr, Roychowdhury S, Routh WD. Experimental and computational flow evaluation of coronary stents. Ann Biomed Eng. 2000;28:386-98.
22. Foin N, Torii R, Mortier P, De Beule M, Viceconte N, Chan PH, Davies JE, Xu XY, Krams R, Di Mario C. Kissing balloon or sequential dilation of the side branch andmain vessel for provisional stenting of bifurcations: lessons from micro-computed tomography and computational simulations. JACC Cardiovasc Interv. 2012;5:47-56.
23. Carrozza JP Jr, Hosley SE, Cohen DJ, Baim DS. In vivo assessment of stent expansion and recoil in normal porcine coronary arteries: differential outcome by stentdesign. Circulation. 1999;100:756-60. (Pubitemid 29383647)
24. Bermejo J, Botas J, García E, Elízaga J, Osende J, Soriano J, Abeytua M, Delcán JL. Mechanisms of residual lumen stenosis after high-pressure stent implantation: aquantitative coronary angiography and intravascular ultrasound study. Circulation. 1998;98:112-8. (Pubitemid 28317890)
25. Takano Y, Yeatman LA, Higgins JR, Currier JW, Ascencio E, Kopelson KA, Tobis JM. Optimizing stent expansion with new stent delivery systems. J Am Coll Cardiol. 2001;38:1622-7. (Pubitemid 33065445)
26. Aziz S, Morris JL, Perry RA, Stables RH. Stent expansion: a combination of delivery balloon underexpansion and acute stent recoil reduces predicted stent diameterirrespective of reference vessel size. Heart. 2007;93:1562-6. (Pubitemid 350205550)
27. Regar E, Schaar J, Serruys PW. Images in cardiology. Acute recoil in sirolimus eluting stent: real time, in vivo assessment with optical coherence tomography. Heart. 2006;92:123. (Pubitemid 43021879)
28. Escaned J, Sandoval J, Arelanno E, Colmenarez H, Gonzalo N, Jimenez P, Alfonso F, Fernandez Ortiz A, Ibanez B, Garcia E, Banuelos C, Hernandez R, Macaya C. Stentrecoil varies with DES type and influences long-term luminal loss. A comparative longitudinal study using a novel methodology for in vivo assessment of stent recoil.EuroIntervention. 2011;7: Supplement M.